Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Market Insights | Japan | 2024

The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and increasing developments in anticancer drugs, limiting the growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Japan from 2019 to 2032.

Related Medtech Insights Reports

Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…
Report
Small-Joint Reconstructive Implants – Market Insights – Japan
The Japanese smalljoint reconstructive implant market, covering shoulder and elbow arthroplasty, exhibits longterm growth potential. Procedure volumes are rising steadily, driven by Japan’s…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…